CONMED (CNMD) Competitors $54.22 +0.15 (+0.28%) Closing price 07/2/2025 03:59 PM EasternExtended Trading$54.50 +0.27 (+0.51%) As of 07:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNMD vs. GKOS, IRTC, NARI, TMDX, BLCO, SLNO, INSP, PRCT, NVST, and LIVNShould you be buying CONMED stock or one of its competitors? The main competitors of CONMED include Glaukos (GKOS), iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Envista (NVST), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. CONMED vs. Its Competitors Glaukos iRhythm Technologies Inari Medical TransMedics Group Bausch + Lomb Soleno Therapeutics Inspire Medical Systems PROCEPT BioRobotics Envista LivaNova Glaukos (NYSE:GKOS) and CONMED (NYSE:CNMD) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation. Is GKOS or CNMD more profitable? CONMED has a net margin of 9.02% compared to Glaukos' net margin of -31.40%. CONMED's return on equity of 14.36% beat Glaukos' return on equity.Company Net Margins Return on Equity Return on Assets Glaukos-31.40% -10.66% -8.06% CONMED 9.02%14.36%5.86% Which has more risk & volatility, GKOS or CNMD? Glaukos has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, CONMED has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Which has stronger earnings and valuation, GKOS or CNMD? CONMED has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlaukos$383.48M15.45-$146.37M-$2.37-43.75CONMED$1.31B1.28$132.42M$3.8014.27 Do analysts rate GKOS or CNMD? Glaukos presently has a consensus target price of $134.67, indicating a potential upside of 29.89%. CONMED has a consensus target price of $62.20, indicating a potential upside of 14.72%. Given Glaukos' stronger consensus rating and higher probable upside, equities analysts plainly believe Glaukos is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Glaukos 1 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.75CONMED 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Do institutionals and insiders have more ownership in GKOS or CNMD? 99.0% of Glaukos shares are held by institutional investors. 5.8% of Glaukos shares are held by company insiders. Comparatively, 3.1% of CONMED shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor GKOS or CNMD? In the previous week, Glaukos and Glaukos both had 6 articles in the media. CONMED's average media sentiment score of 0.97 beat Glaukos' score of 0.81 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glaukos 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCONMED beats Glaukos on 9 of the 15 factors compared between the two stocks. Get CONMED News Delivered to You Automatically Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNMD vs. The Competition Export to ExcelMetricCONMEDMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$1.67B$15.74B$5.54B$20.53BDividend Yield1.48%1.41%5.39%3.77%P/E Ratio14.2718.6926.2327.85Price / Sales1.282.33413.2337.49Price / Cash8.0516.9736.1321.91Price / Book1.743.858.044.55Net Income$132.42M$430.42M$3.15B$984.95M7 Day Performance3.55%2.72%1.44%2.31%1 Month Performance-4.66%1.43%3.62%4.85%1 Year Performance-19.64%22.13%34.68%13.81% CONMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNMDCONMED4.6697 of 5 stars$54.22+0.3%$62.20+14.7%-19.1%$1.67B$1.31B14.273,900News CoveragePositive NewsGKOSGlaukos4.3459 of 5 stars$96.80-3.3%$134.67+39.1%-12.8%$5.53B$383.48M-40.84780IRTCiRhythm Technologies1.2379 of 5 stars$150.95+3.6%$138.60-8.2%+44.8%$4.82B$591.84M-48.072,000Positive NewsInsider TradeNARIInari Medical0.4688 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800TMDXTransMedics Group1.6004 of 5 stars$127.53+3.2%$127.33-0.2%-14.3%$4.31B$441.54M93.77210Positive NewsBLCOBausch + Lomb3.3738 of 5 stars$12.01+2.3%$15.54+29.5%-6.2%$4.25B$4.79B-11.6613,500SLNOSoleno Therapeutics4.2194 of 5 stars$81.42+1.8%$107.10+31.5%+117.0%$4.10BN/A-17.6230INSPInspire Medical Systems4.8514 of 5 stars$129.88-0.8%$211.91+63.2%-2.7%$3.83B$840.11M59.851,246Positive NewsPRCTPROCEPT BioRobotics2.2019 of 5 stars$58.74-2.5%$90.00+53.2%-7.9%$3.25B$224.50M-34.55430NVSTEnvista3.5958 of 5 stars$18.90+0.1%$20.23+7.0%+23.5%$3.20B$2.51B-2.8912,300LIVNLivaNova2.9208 of 5 stars$45.57+0.1%$59.29+30.1%-12.9%$2.48B$1.28B-11.142,900 Related Companies and Tools Related Companies GKOS Competitors IRTC Competitors NARI Competitors TMDX Competitors BLCO Competitors SLNO Competitors INSP Competitors PRCT Competitors NVST Competitors LIVN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNMD) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CONMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNMD Stock Alerts